Trials / Sponsors / Santen Pharmaceutical (Taiwan) Co., LTD
Santen Pharmaceutical (Taiwan) Co., LTD
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glau Ocular Surface Disease, Primary Open Angle Glaucoma | — | 2021-09-01 |
| Completed | Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Gla Glaucoma, Primary Open Angle | N/A | 2018-04-02 |